EVALUATION OF ANALGESIC ACTIVITY OF SOME NOVEL SUBSTITUTED L-ARGININE ANALOGUES
HTML Full TextEVALUATION OF ANALGESIC ACTIVITY OF SOME NOVEL SUBSTITUTED L-ARGININE ANALOGUES
S. K. Arifa Begum1, M. Madhuri1, A.Rajani1 and K. Hemamalini*2
Sree Dattha Institute of Pharmacy 1, Sheriguda, Ibrahimpatnam, R.R District.Andhra Pradesh, India
Department of Pharmacology 2, Teegala Ram Reddy College of Pharmacy, Meerpet, Hyderabad, Andhra Pradesh, India
ABSTRACT:A series of novel L-arginine analogues were synthesized characterized and screened for analgesic activity by acetic acid induced analgesia model. The purity of the synthesized compounds has been characterized by various analytical techniques such as UV, FTIR and TLC. The synthesized compounds were evaluated for analgesic activity by acetic acid induced analgesia in mice using paracetamol as the standard drug for comparing the test results. The study concluded that the compound 1, 2, 3 and 4 were found to exhibit significant anti-pyretic action.
Keywords:
Substituted l-Arginine analogues, analgesic activity, Acetic acid |
induced analgesia model, Paracetamol
INTRODUCTION: Analgesics are the primary need for patients to get rid of any kind of pain. Pain is one of the basic symptoms of all human ailments which is a sensorial modality and primary protective. Analgesics only relieve pain in a particular complaint without affecting its cause1. A prolonged painful stimulation may generate increased blood flow and inflammation, and vice versa, inflammation may lead to pain2.The effect of Nitricoxide (NO) on peripheral nociception and with its local vasodilation, spinal pain associated with herniated discs can be classified as peripheral nociception because the spine is in this case the site of inflammation3, 4.
It has been concluded that pain associated with Rheumatoid arthritis (RA) is due to synovial inflammation, and that pain in RA is associated with enhanced substance P and IL-2 in the synovial fluid. Both these substances induce production of Nitric oxide. It has been shown in murine models that NO enhances the sensitivity of peripheral nociceptors and that inhibitors of Nitric oxide synthase can act as analgesic agents at the cerebral, spinal and peripheral levels5, 6. There is a direct evidence that NO can induce pain locally.
Intracutaneous injections of NO to humans were shown to induce dose-dependent local pain and similar findings were obtained more recently when NO was injected intravenously. Identification of N-methyl-L-Arginine (L-NMA) as the first inhibitor of NO biosynthesis led to the design of selective iNOS inhibitors7. Hence the present study was planned to synthesize some novel substituted L-arginine analogues and to evaluate for anti-inflammatory activity.
MATERIALS AND METHODS:
Synthetic Chemistry
STEP-1 (Synthesis of 4-benzylidine-2-phenyl oxazole – 5- ones): A mixture of benzoyl glycine, redistilled benzaldehyde, acetic acid and anhydrous sodium acetate was heated on an electric hot plate with stirring. On liquefaction it was heated for 2hrs and ethanol was added slowly and the mixture was allowed to stand overnight. The product obtained is washed with boiling water and dried at 100oC. The product obtained in step-I was used in step-2 for further synthesis.
STEP-II (Synthesis of substituted L-arginine analogues):
The product obtained in step-I was reacted with unsubstituted L-Arginine and some substituted L-Arginine in alkali like NaOH and acetone which results in clear solution after 2-3hrs of reaction. The solution thus obtained was acidified by the addition of HCl. The products separated were unsubstituted and some substituted L-arginine analogues. L-Arginine analogues were washed with cold water and dried. The compounds thus obtained were used for screening analgesic activity after purification and characterization. The %yield, melting points, Rf values and molecular formula of various substituted L-arginine analogues are tabulated in Table 1.
TABLE: 1-PHYSICAL DATA OF SUBSTITUTED L-ARGININE ANALOGUES (1-11)
Compound Name | R | Melting Point (oC) | Rf value | % yield | Molecular Formula |
1 | H | 205 | 0.62 | 76 | C22H25N5O4 |
2 | 4-Cl | 180 – 185 | 0.76 | 66 | C22H24N5O4Cl |
3 | 4-OCH3 | 210 | 0.48 | 65 | C23H27N5O5 |
4 | 4-OH | 190 | 0.66 | 45 | C22H25N5O5 |
5 | 4-OH, 3-OCH3 | 175 – 177 | 0.82 | 47 | C23H27N5O6 |
6 | 5-Br, 4-OH, 3-OCH3 | 170 – 172 | 0.72 | 46 | C23H26N5O6Br |
7 | 4-N(CH3)2 | 198 – 200 | 0.56 | 79 | C24H30N6O4 |
8 | 4–(CH3)2 | 190 | 0.692 | 55 | C25H31N5O4 |
9 | 4-NO2 | 195 | 0.833 | 51 | C22H24N6O6 |
10 | 4-CH3 | 205 | 0.44 | 53 | C23H27N5O4 |
11 | 5-I, 4-OH, 3-OCH3 | 207 | 0.51 | 45 | C23H26N5O6I |
Preparation of the test and standard drug
The synthesized l-arginine analogues were insoluble in water. So, the test compounds and standard drug were suspended 1% carboxy methyl cellulose and prepared in the concentration of 100mg.kg body weight.
Animals
Male albino mice weighing (18-25g) were used for the evaluation of analgesic activity. They were kept in polypropylene cages at 25 ± 2oC, with relative humidity of 45 – 55% under 12 hrs light and dark cycles. All the animals were acclimatized to the laboratory conditions of SreeDattha Institute of Pharmacy for a week before use. They were fed with standard animal feed and water ad libitum.
Analgesic activity
Pain is induced by injecting irritants into the peritoneal cavity of mice. 0.1ml of 0.6% solution of glacial acetic acid is injected intraperitoneally to mice with a weight between 18-25gms8. Test
animals were divided into groups of 6 animals each and subjected to fasting overnight. Test and standard drugs were administered at various pretreatment times prior to acetic acid administration. The mice are placed individually in a glass beaker and are allowed to elapse for 5minutes. The mice were then observed for a period of ten minutes and the number of writhes was recorded for each animal. For scoring purposes, a writhe is indicated by stretching of the abdomen with simultaneous stretching of at least one hind limb. The formula for computing % inhibition is as follows and the results are tabulated in Table 2.
% inhibition = Avg. writhes in control – Avg. writhes in test / Writhes in control X 100
Those compounds which inhibit writhing more than 70% were considered to possess good activity and those with less than 70% inhibition were considered to have minimal activity.
TABLE: 2 ANALGESIC ACTIVITY OF L-ARGININE ANALOGUES
Compound | Dose (mg/kg) | No. of writhes
(Mean ±SEM) |
% inhibition | Significance |
Control | --- | 66.33 ± 2.29 | -- | --- |
Paracetamol | 100 | 37.33 ± 2.41 | 43.72 | P < 0.001 |
Compound 1 | 100 | 28.98 ± 2.34 | 56.30 | P < 0.001 |
Compound 2 | 100 | 31.87 ± 1.98 | 51.95 | P < 0.001 |
Compound 3 | 100 | 29.33 ± 1.82 | 55.78 | P < 0.001 |
Compound 4 | 100 | 32.67 ± 2.36 | 50.74 | P < 0.001 |
Compound 5 | 100 | 38.76 ± 2.41 | 41.56 | P < 0.001 |
Compound 6 | 100 | 34.79 ± 1.76 | 47.55 | P < 0.001 |
Compound 7 | 100 | 37.74 ± 2.37 | 43.10 | P < 0.001 |
Compound 8 | 100 | 38.68 ± 2.46 | 41.68 | P < 0.001 |
Compound 9 | 100 | 38.33 ± 1.86 | 42.21 | P < 0.001 |
Compound 10 | 100 | 37.76 ± 2.32 | 43.07 | P < 0.001 |
Compound 11 | 100 | 52.33 ± 3.93 | 21.10 | NS |
NS: Not significant
RESULTS AND DISCUSSION: All the L-Arginine analogues synthesized have good yield value. The melting points of all the compounds were determined in an open capillary tube using an electro thermal digital meting point apparatus and are uncorrected. The compounds were characterized using analytical techniques such as UV, TLC and FT-IR. All the Compounds were screened for analgesic activity and the results were compared with that of the standard drug. The study revealed that Compound 1, 2, 3 and 4 exhibited very significant analgesic action while compound 11 has shown very minimum anti-pyretic action. The compounds can be screened for anti-pyretic action using other screening models to assess their activity on a broader scale which is our future part of the research work.
ACKNOWLEDGEMENTS: Authors express their sincere gratitude to the management and Directors of Sree Dattha Institutions for their constant motivation and encouragement.
REFERENCES:
- Mate, GS.,Naikwade, NS., Chowki, CSAA., Patil, SB., Evaluation of anti-nociceptive activity of Cissusquandrangularis on albino mice, Int. J. Green Pharm.;2:118-121, 2008.
- Olgart L, Kerezondius NP, Nerve pulp interactions, Arch Oral Biol.; 39: 47-54, 1994.
- Kang JD, Georgescus HI, Meityrelarkin D, Herniated cervical intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6 and prostaglandin E2, Spine; 21:271-277, 1996.
- Palmgreen J, Gronbald M, Virri J, Immuno-histochemical demonstration of sensory and autonomic nerve terminals in herniated lumbar disc tissue, Spine; 100: 10-15, 1996.
- Malmberg AB, Yaksh TL, Spinal nitric oxide synthasis inhibition blocks NMDA- induced thermal hyperalgesia and produces antinociception in the formalin tests in rats, Pain; 54: 291-300, 1993.
- Ignarro LJ, Aeberhard FE, Henderson SA, The biology of nitric oxide, E.A.; 3:5th ed. London, Portland, 1996.
- Salvemani R, Seibert k, Marino MH, New concepts in inflammation and therapy, DN and P.; 9(4):204-214, 1996.
- Taber RI, Greenhouse DD, Rendell JK, Irwin S, Agonist and antagonist interations in opioids on acetic acid induced abdominal stretchings in mice, J. Phar. Exp. Ther.; 169: 29-38, 1969.
How to cite this article:
Arifa Begum SK, Madhuri M., Rajani A.and Hemamalini K.: Evaluation of analgesic activity of some novel substituted l-arginine analogues. Int J Pharm Sci Res 2014; 5(5): 2038-40.doi: 10.13040/IJPSR.0975-8232.5 (5).2038-40.
All © 2013 are reserved by International Journal of Pharmaceutical Sciences and Research. This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike3.0 Unported License
Article Information
56
2038-2040
394KB
1184
English
IJPSR
S. K. Arifa Begum, M. Madhuri, A.Rajani and K. Hemamalini*
Associate Professor & HOD, Department of pharmacology, Teegala Ram Reddy College of Pharmacy, Meerpet, Hyderabad, AP, India
rajani_adepu85@yahoo.com
19 December, 2013
10 January, 2014
16 April, 2014
http://dx.doi.org/10.13040/IJPSR.0975-8232.5(5).2038-40
01, May 2014